Month: August 2026

Research participants are at the heart of the NIH mission to transform discovery into health. By volunteering to take part in research, participants are key partners in the success of the biomedical research enterprise by helping to advance scientific understanding, improve treatments, and shape a healthier future for everyone.

To uphold our commitment to our partners in research, NIH is announcing a new policy proposal to ensure research participants receive the results of the studies they participate in.

All are encouraged to comment on NIH’s Draft Policy for Sharing Summary Level Study Results with Clinical Research Participants. Comments on the Draft Policy will be accepted until October 26, 2026, and must be submitted through the online comment form found at: https://osp.od.nih.gov/comment-form-draft-sharing-summary-results-policy/. 

Additional information on NIH’s approach to the sharing of summary level and individual level study results with clinical research participants can also be found on the OSP website.

Questions may be sent to [email protected]. 

Today, NIH has issued a request for public comment on its Draft Biosafety Policy for Research Involving Biohazards(Biosafety Policy).

In September 2025, NIH announced its intention to strengthen and modernize biosafety oversight. Since then, NIH has extensively engaged stakeholders to inform the development of a new oversight paradigm better calibrated to risk.  

NIH invites stakeholders to provide feedback on the Draft Biosafety Policy as well as the associated Draft Incident Reporting Template, and Draft Meeting Minutes Template. Comments must be submitted though the online portal found at: https://osp.od.nih.gov/comment-form-draft-nih-biosafety-policy-for-research-involving-biohazards and will be accepted until October 19, 2026.

To further assist stakeholders in interpreting the Draft Biosafety Policy, NIH has also developed a summary table of proposed changes. 

Questions may be sent to [email protected].  

If you are not yet a subscriber to this listserv, please sign up here.